Barclays PLC Has $2 Million Stake in IMAX Co. (NYSE:IMAX)

Barclays PLC lowered its holdings in IMAX Co. (NYSE:IMAX - Free Report) by 78.7% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 77,960 shares of the company's stock after selling 288,194 shares during the period. Barclays PLC owned approximately 0.15% of IMAX worth $1,995,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently made changes to their positions in the business. Blue Trust Inc. boosted its stake in shares of IMAX by 138.5% in the fourth quarter. Blue Trust Inc. now owns 966 shares of the company's stock valued at $25,000 after buying an additional 561 shares during the period. Wealthfront Advisers LLC bought a new stake in shares of IMAX during the 4th quarter valued at $217,000. Cornerstone Investment Partners LLC acquired a new stake in shares of IMAX during the 4th quarter worth $248,000. Savant Capital LLC bought a new position in shares of IMAX in the fourth quarter worth $249,000. Finally, US Bancorp DE raised its stake in IMAX by 60.3% in the fourth quarter. US Bancorp DE now owns 12,276 shares of the company's stock valued at $314,000 after purchasing an additional 4,620 shares in the last quarter. Institutional investors and hedge funds own 93.51% of the company's stock.

Analysts Set New Price Targets

Several research firms have commented on IMAX. StockNews.com raised shares of IMAX from a "hold" rating to a "buy" rating in a report on Friday, April 25th. Benchmark reissued a "buy" rating and issued a $30.00 price objective on shares of IMAX in a research note on Thursday, April 10th. Barrington Research reaffirmed an "outperform" rating and issued a $32.00 target price on shares of IMAX in a report on Thursday, April 24th. Macquarie boosted their price target on IMAX from $30.00 to $32.00 and gave the stock an "outperform" rating in a report on Friday, April 25th. Finally, Wedbush reiterated an "outperform" rating and issued a $32.00 target price on shares of IMAX in a research report on Thursday, April 17th. One equities research analyst has rated the stock with a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, IMAX has a consensus rating of "Buy" and an average target price of $30.56.

IMAX Stock Performance

IMAX stock opened at $24.15 on Friday. IMAX Co. has a 52-week low of $14.94 and a 52-week high of $27.77. The company has a market capitalization of $1.30 billion, a P/E ratio of 49.29, a PEG ratio of 1.49 and a beta of 0.91. The company has a fifty day moving average price of $24.51 and a 200-day moving average price of $24.40.

IMAX (NYSE:IMAX - Get Free Report) last released its quarterly earnings results on Wednesday, April 23rd. The company reported $0.13 EPS for the quarter, beating analysts' consensus estimates of $0.11 by $0.02. The firm had revenue of $86.67 million for the quarter, compared to analyst estimates of $82.95 million. IMAX had a return on equity of 8.60% and a net margin of 7.40%. The business's revenue was up 9.6% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.15 EPS. As a group, sell-side analysts forecast that IMAX Co. will post 0.91 earnings per share for the current fiscal year.

About IMAX

IMAX Corporation, together with its subsidiaries, operates as a technology platform for entertainment and events worldwide. The company operates in two segments, Content Solutions and Technology Products and Services. The company offers IMAX DMR, a proprietary technology that digitally remasters films and other content into IMAX formats for distribution to the IMAX network; IMAX Enhanced that provides end-to-end technology across streaming content and entertainment devices at home; and SSIMWAVE, an AI-driven video quality solutions for media and entertainment companies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.